David Marcilla - Concepedia

Author

David Marcilla

Hospital Universitario Virgen del Rocío

Also Known As

D Marcilla, D. Marcilla, David Marcilla, marcilla, david

Publications

412

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen del Rocío Instituto de Biomedicina de Sevilla Universidad de Sevilla Centro de Investigación Biomédica en Red de Cáncer Hospital Universitario Son Espases

About

David Marcilla is an author at Hospital Universitario Virgen del Rocío specializing in pathology, medicine, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	198
2	Pathology	4	4	198
3	Cell Biology	1	1	15
4	Orthopaedics	1	1	42
5	Pharmacology	1	1	15

David Marcilla

Publications

324

Citations

H-Index

Page 1

	Year	Citations
Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial Javier Martín‐Broto, Josefina Cruz, Nicolas Penel, The Lancet Oncology Surgical OncologyMedicineSystemic TreatmentTheranosticsPathology	2020	84
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS) Javier Martín‐Broto, Andrés Redondo, Claudia Valverde, Annals of Oncology Spanish GroupOsteosarcoma PatientsOncologyStandard ChemotherapyMetronomic Therapy	2017	57
Lower Extremity Fibro-Adipose Vascular Anomaly (FAVA): A New Case of a Newly Delineated Disorder Israel Fernández‐Pineda, David Marcilla, Francisco Javier Downey-Carmona, Annals of Vascular Diseases ObesityMetabolic SyndromeFibrosisVasculitisNew Case	2014	42
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/CDKN2A Javier Martín‐Broto, Jerónimo Martínez-García, David S. Moura, Signal Transduction and Targeted Therapy	2023	33
Hippo pathway effectors YAP1/TAZ induce an <i>EWS–FLI1</i> ‐opposing gene signature and associate with disease progression in Ewing sarcoma Pablo Rodríguez‐Núñez, Laura Romero‐Pérez, Ana Teresa Amaral, The Journal of Pathology	2019	31
Trabectedin Plus Radiotherapy for Advanced Soft-Tissue Sarcoma: Experience in Forty Patients Treated at a Sarcoma Reference Center Nadia Hindi, Irene Carrasco García, Alberto Sánchez-Camacho, Cancers	2020	20
Evaluation of NAB2-STAT6 Fusion Variants and Other Molecular Alterations as Prognostic Biomarkers in a Case Series of 83 Solitary Fibrous Tumors Carmen Salguero‐Aranda, Paula Martínez-Reguera, David Marcilla, Cancers	2021	19
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients Lourdes Hontecillas‐Prieto, Daniel J. García-Domínguez, Diego Pascual Vaca, Oncotarget PathologyCancer BiologyMultidrug Resistance TransportersTumor BiologyDrug Resistance	2017	15
Identification of Novel/Rare EWSR1 Fusion Partners in Undifferentiated Mesenchymal Neoplasms Carmen Salguero‐Aranda, Elena Di Blasi, L. Alfaro Galán, International Journal of Molecular Sciences	2024	12
Myxoid liposarcoma: MRI features with histological correlation V. M. Encinas Tobajas, C. Almeida, David Marcilla, Radiología (English Edition)	2022	11

Page 1